» Articles » PMID: 15760110

Neural Retina Limits the Nonviral Gene Transfer to Retinal Pigment Epithelium in an in Vitro Bovine Eye Model

Overview
Journal AAPS J
Specialty Pharmacology
Date 2005 Mar 12
PMID 15760110
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the permeation of liposomal and polymeric gene delivery systems through neural retina into retinal pigment epithelium (RPE) and determined the roles of various factors in permeation and subsequent uptake of the delivery systems by RPE. Anterior parts and vitreous of fresh bovine eyes were removed. Retina was left intact or peeled away. Complexes of ethidium monoazide (EMA)-labeled plasmid DNA and cationic carriers (polyethyleneimine, poly-L-lysine, DOTAP liposomes) were pipetted on the retina or RPE. Two hours later the neural retina was removed, if present, and the RPE cells were detached. Contaminants were removed by sucrose centrifugation, and the RPE cells were analyzed for DNA uptake by flow cytometry. Cellular uptake of FITC-dextrans (molecular weight [mw] 20,000, 500,000 and 2,000,000), FITC-poly-L-lysine (mw 20,000), FITC-labeled oligonucleotide (15-mer), and naked EMA-labeled plasmid DNA was determined after pipetting the solutions on the RPE or neural retina. Location of the fluorescent materials in the retina was visualized with fluorescence microscopy. Neural retina decreased the cellular uptake of DNA complexes by an order of magnitude, the uptake of FITC-dextrans slightly, whereas delivery of polycationic FITC-poly-L-lysine to RPE was almost completely inhibited. Neural retina decreased the cellular uptake of FITC-oligonucleotides, while the uptake of uncomplexed plasmid was always negligible. Conclusions from FACS and fluorescence microscopy were similar: delivery of polymeric and liposomal DNA complexes into RPE are limited by the neural retina. This is due to the size and positive charge of the complexes.

Citing Articles

Translational physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies.

Naware S, Bussing D, Shah D J Pharmacokinet Pharmacodyn. 2023; 51(5):493-508.

PMID: 37558929 DOI: 10.1007/s10928-023-09881-9.


Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities.

Chien Y, Hsiao Y, Chou S, Lin T, Yarmishyn A, Lai W J Nanobiotechnology. 2022; 20(1):511.

PMID: 36463195 PMC: 9719668. DOI: 10.1186/s12951-022-01717-x.


Pharmacokinetics of Pullulan-Dexamethasone Conjugates in Retinal Drug Delivery.

Kickova E, Sadeghi A, Puranen J, Tavakoli S, Sen M, Ranta V Pharmaceutics. 2022; 14(1).

PMID: 35056906 PMC: 8779473. DOI: 10.3390/pharmaceutics14010012.


Synthesis and Characterization of Novel Succinyl Chitosan-Dexamethasone Conjugates for Potential Intravitreal Dexamethasone Delivery.

Dubashynskaya N, Bokatyi A, Golovkin A, Kudryavtsev I, Serebryakova M, Trulioff A Int J Mol Sci. 2021; 22(20).

PMID: 34681619 PMC: 8535746. DOI: 10.3390/ijms222010960.


Exploring the Impact of Morphology on the Properties of Biodegradable Nanoparticles and Their Diffusion in Complex Biological Medium.

Ridolfo R, Tavakoli S, Junnuthula V, Williams D, Urtti A, van Hest J Biomacromolecules. 2020; 22(1):126-133.

PMID: 32510218 PMC: 7805011. DOI: 10.1021/acs.biomac.0c00726.


References
1.
Hauswirth W, Beaufrere L . Ocular gene therapy: quo vadis?. Invest Ophthalmol Vis Sci. 2000; 41(10):2821-6. View

2.
Galileo D, Hunter K, Smith S . Stable and efficient gene transfer into the mutant retinal pigment epithelial cells of the Mitf(vit) mouse using a lentiviral vector. Curr Eye Res. 1999; 18(2):135-42. DOI: 10.1076/ceyr.18.2.135.5376. View

3.
Ruponen M, Ronkko S, Honkakoski P, Pelkonen J, Tammi M, Urtti A . Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J Biol Chem. 2001; 276(36):33875-80. DOI: 10.1074/jbc.M011553200. View

4.
Haeseleer F, Imanishi Y, Saperstein D, Palczewski K . Gene transfer mediated by recombinant baculovirus into mouse eye. Invest Ophthalmol Vis Sci. 2001; 42(13):3294-300. PMC: 1436034. View

5.
Jabs D, Griffiths P . Fomivirsen for the treatment of cytomegalovirus retinitis. Am J Ophthalmol. 2002; 133(4):552-6. DOI: 10.1016/s0002-9394(02)01325-9. View